Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 15, 2015 - Issue sup1: Proceedings of the Fourth International Symposium on Thymosins in Health and Disease
Submit an article Journal homepage
3,127
Views
18
CrossRef citations to date
0
Altmetric
Editorial

Thymosin alpha-1 treatment in chronic hepatitis B

Xiaoning WuCapital Medical University, Liver Research Center, Beijing Friendship Hospital, Beijing Key Laboratory of Translational Medicine in Liver Cirrhosis, 95 Yong-an Road, Xi-Cheng District, Beijing 100050, China+86 10 6313 9019; +86 10 6302 3261; [email protected]; [email protected];National Clinical Research Center of Digestive Diseases, 100050 Beijing, China
,
Jidong JiaCapital Medical University, Liver Research Center, Beijing Friendship Hospital, Beijing Key Laboratory of Translational Medicine in Liver Cirrhosis, 95 Yong-an Road, Xi-Cheng District, Beijing 100050, China+86 10 6313 9019; +86 10 6302 3261; [email protected]; [email protected];National Clinical Research Center of Digestive Diseases, 100050 Beijing, China
&
Hong YouCapital Medical University, Liver Research Center, Beijing Friendship Hospital, Beijing Key Laboratory of Translational Medicine in Liver Cirrhosis, 95 Yong-an Road, Xi-Cheng District, Beijing 100050, China+86 10 6313 9019; +86 10 6302 3261; [email protected]; [email protected];National Clinical Research Center of Digestive Diseases, 100050 Beijing, China
Pages 129-132 | Published online: 01 Feb 2015

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Muhammad Shahbaz Aslam, Iram Gull, Malik Siddique Mahmood, Muhammad Mudassir Iqbal, Zaigham Abbas, Imran Tipu, Aftab Ahmed & Muhammad Amin Athar. (2020) High yield expression, characterization, and biological activity of IFNα2-Tα1 fusion protein. Preparative Biochemistry & Biotechnology 50:3, pages 281-291.
Read now
Claudia Matteucci, Ayele Argaw-Denboba, Emanuela Balestrieri, Alessandro Giovinazzo, Martino Miele, Cartesio D’Agostini, Francesca Pica, Sandro Grelli, Maurizio Paci, Antonio Mastino, Paola Sinibaldi Vallebona, Enrico Garaci & Carlo Tomino. (2018) Deciphering cellular biological processes to clinical application: a new perspective for Tα1 treatment targeting multiple diseases. Expert Opinion on Biological Therapy 18:sup1, pages 23-31.
Read now
Francesca Pica, Roberta Gaziano, Ida Antonia Casalinuovo, Gabriella Moroni, Cristina Buè, Dolores Limongi, Cartesio D’Agostini, Carlo Tomino, Roberto Perricone, Anna Teresa Palamara, Paola Sinibaldi Vallebona & Enrico Garaci. (2018) Serum thymosin alpha 1 levels in normal and pathological conditions. Expert Opinion on Biological Therapy 18:sup1, pages 13-21.
Read now

Articles from other publishers (15)

Yiying Xue, Husheng Mei, Yisa Chen, James D. Griffin, Qingsong Liu, Ellen Weisberg & Jing Yang. (2023) Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS‐CoV‐2. MedComm 4:3.
Crossref
Jun-feng Chen, Shu-ru Chen, Zi-ying Lei, Hui-juan Cao, Shao-quan Zhang, Wei-zhen Weng, Jing Xiong, Deng-na Lin, Jing Zhang, Yu-bao Zheng, Zhi-liang Gao & Bing-liang Lin. (2022) Safety and efficacy of Thymosin α1 in the treatment of hepatitis B virus-related acute-on-chronic liver failure: a randomized controlled trial. Hepatology International.
Crossref
Norah Htet Htet, Cho Naing, Sompong Vongpunsawad, Thin Thin Win & Yong Poovorawan. (2022) Thymosin-ɑ1 for people with chronic hepatitis B. Cochrane Database of Systematic Reviews 2022:3.
Crossref
Max E. Distler, Michelle H. Teplensky, Katherine E. Bujold, Caroline D. Kusmierz, Michael Evangelopoulos & Chad A. Mirkin. (2021) DNA Dendrons as Agents for Intracellular Delivery. Journal of the American Chemical Society 143:34, pages 13513-13518.
Crossref
Muhammad Shahbaz Aslam, Syed Zohaib Javaid Zaidi, Rabail Hassan Toor, Iram Gull, Muhammad Mudassir Iqbal, Zaigham Abbas, Imran Tipu, Aftab Ahmed, Muhammad Amin Athar, Christian Harito & Sammer-ul Hassan. (2021) Interferon α2–Thymosin α1 Fusion Protein (IFNα2–Tα1): A Genetically Engineered Fusion Protein with Enhanced Anticancer and Antiviral Effect. Materials 14:12, pages 3318.
Crossref
Dan Peng, Hai-Yan Xing, Chen Li, Xian-Feng Wang, Min Hou, Bin Li & Jian-Hong Chen. (2020) The clinical efficacy and adverse effects of Entecavir plus Thymosin alpha-1 combination therapy versus Entecavir Monotherapy in HBV-related cirrhosis: a systematic review and meta-analysis. BMC Gastroenterology 20:1.
Crossref
Nadine BeckmannChristen E. SalyerPeter A. CrisologoVanessa NomelliniCharles C. Caldwell. (2020) Staging and Personalized Intervention for Infection and Sepsis. Surgical Infections 21:9, pages 732-744.
Crossref
Renhao Peng, Caoying Xu, Heng Zheng & Xingzhen Lao. (2020) Modified Thymosin Alpha 1 Distributes and Inhibits the Growth of Lung Cancer in Vivo. ACS Omega 5:18, pages 10374-10381.
Crossref
Liyuan Qian, Hongxia Fan, Ying Ju, Lizhao Chen, Xin Li, Xin Ye, Yunjing Luo, Changfei Li & Songdong Meng. (2019) A peptide-based inhibitor of gp96 suppresses HBsAg expression and HBV replication by upregulation of p53. Journal of General Virology 100:8, pages 1241-1252.
Crossref
Roger Davies, Kieran O’Dea & Anthony Gordon. (2018) Immune therapy in sepsis: Are we ready to try again?. Journal of the Intensive Care Society 19:4, pages 326-344.
Crossref
Fanwen Wang, Tingting Yu, Heng Zheng & Xingzhen Lao. (2018) Thymosin Alpha1-Fc Modulates the Immune System and Down-regulates the Progression of Melanoma and Breast Cancer with a Prolonged Half-life. Scientific Reports 8:1.
Crossref
Zhijian Li, Qingxi Min, Haoji Huang, Ruixuan Liu, Yongyan Zhu & Quanhong Zhu. (2018) Design, synthesis and biological evaluation of seco-A-pentacyclic triterpenoids-3,4-lactone as potent non-nucleoside HBV inhibitors. Bioorganic & Medicinal Chemistry Letters 28:9, pages 1501-1506.
Crossref
P. H. Naylor & M. G. Mutchnick. (2018) Immunotherapy for hepatitis B in the direct acting antiviral era: Reevaluating the thymosin α1 efficacy trials in the light of a combination therapy approach. Journal of Viral Hepatitis 25:1, pages 4-9.
Crossref
Edward A. Pham, Ryan B. Perumpail, Benjamin J. Fram, Jeffrey S. Glenn, Aijaz Ahmed & Robert G. Gish. (2016) Future Therapy for Hepatitis B Virus: Role of Immunomodulators. Current Hepatology Reports 15:4, pages 237-244.
Crossref
H. Ueda, S.K. Halder, H. Matsunaga, K. Sasaki & S. Maeda. (2016) Neuroprotective impact of prothymosin alpha-derived hexapeptide against retinal ischemia–reperfusion. Neuroscience 318, pages 206-218.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.